Roivant Sciences Ltd (ROIV)

Sep 30, 2025

Can Roivant Sciences Ltd. (87S) stock double in coming yearsQuarterly Profit Summary & AI Enhanced Trading Signals - newser.com

Sep 30, 2025

Sep 30, 2025

Will Roivant Sciences Ltd. continue its uptrendEarnings Recap Report & Fast Moving Stock Watchlists - newser.com

Sep 30, 2025

Sep 30, 2025

Roivant Sciences stock poised for growth, Goldman Sachs reiterates Buy By Investing.com - Investing.com South Africa

Sep 30, 2025

Sep 30, 2025

Roivant Sciences stock poised for growth, Goldman Sachs reiterates Buy - Investing.com India

Sep 30, 2025

Sep 30, 2025

Roivant Sciences Ltd.’s volatility index tracking explainedGap Up & Growth Focused Stock Reports - newser.com

Sep 30, 2025

Sep 30, 2025

Is Roivant Sciences Ltd. (87S) stock undervalued historicallyMarket Activity Summary & AI Driven Stock Price Forecasts - newser.com

Sep 30, 2025

Sep 30, 2025

Why retail investors pile into Roivant Sciences Ltd. stockBond Market & Real-Time Stock Price Movement Reports - newser.com

Sep 30, 2025

Sep 29, 2025

Why Roivant Sciences Ltd. (87S) stock attracts wealthy investorsOil Prices & Accurate Technical Buy Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

What sentiment indicators say about Roivant Sciences Ltd. stockProfit Target & Risk Controlled Stock Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Long term hold vs stop loss in Roivant Sciences Ltd.Trade Analysis Report & Long-Term Safe Investment Plans - newser.com

Sep 29, 2025

Sep 29, 2025

LVW Advisors LLC Makes New $199,000 Investment in Roivant Sciences Ltd. $ROIV - MarketBeat

Sep 29, 2025

Sep 29, 2025

Can Roivant Sciences Ltd. stock deliver consistent earnings growth2025 Price Action Summary & Expert Curated Trade Ideas - newser.com

Sep 29, 2025

Sep 28, 2025

What analysts say about Roivant Sciences Ltd stockDividend Stability Analysis & Fast Growing Investment Ideas - earlytimes.in

Sep 28, 2025

Sep 27, 2025

How Investors May Respond To Roivant Sciences (ROIV) Positive Phase 3 Results for Brepocitinib in Dermatomyositis - simplywall.st

Sep 27, 2025

Sep 27, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Sep 27, 2025

Sep 26, 2025

Is Roivant Sciences Ltd a good long term investmentVolatility Index Analysis & These Stocks Are Just Getting Started - Early Times

Sep 26, 2025

Sep 25, 2025

Transcript : Roivant Sciences Ltd. Presents at Bernstein 2nd Annual Global Healthcare Conference, Sep-23-2025 01 - MarketScreener

Sep 25, 2025

Sep 24, 2025

Transcript : Roivant Sciences Ltd. Presents at Bank of America Global Healthcare Conference 2025, Sep-24-2025 09 - MarketScreener

Sep 24, 2025

Sep 24, 2025

Roivant Sciences president Venker sells $25.5m in shares By Investing.com - ng.investing.com

Sep 24, 2025

Sep 24, 2025

Roivant Sciences at Bank of America Global Healthcare: Strategic Insights By Investing.com - Investing.com Australia

Sep 24, 2025

Sep 24, 2025

analysts-double-sales-forecasts-for-roivant-s-brepocitinib-after-trial-success-93143405 - S&P Global

Sep 24, 2025

Sep 23, 2025

Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 611,000 Shares - MarketBeat

Sep 23, 2025

Sep 23, 2025

Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 416,182 Shares - MarketBeat

Sep 23, 2025

Sep 23, 2025

Roivant Sciences president Venker sells $25.5m in shares - Investing.com

Sep 23, 2025

Sep 23, 2025

Are You Looking for a Top Momentum Pick? Why Roivant Sciences Ltd. (ROIV) is a Great Choice - Yahoo Finance

Sep 23, 2025

Sep 23, 2025

Roivant Sciences (NASDAQ:ROIV) Given New $22.00 Price Target at Leerink Partners - MarketBeat

Sep 23, 2025

Sep 23, 2025

Inspire Investing LLC Invests $303,000 in Roivant Sciences Ltd. $ROIV - MarketBeat

Sep 23, 2025

Sep 23, 2025

The Goldman Sachs Group Boosts Roivant Sciences (NASDAQ:ROIV) Price Target to $24.00 - MarketBeat

Sep 23, 2025

Sep 23, 2025

Roivant Sciences (NASDAQ:ROIV) Price Target Raised to $20.00 at HC Wainwright - MarketBeat

Sep 23, 2025

Sep 22, 2025

Bank of America Forecasts Strong Price Appreciation for Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat

Sep 22, 2025

Sep 22, 2025

Roivant Sciences (NASDAQ:ROIV) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

Sep 22, 2025

Sep 22, 2025

Guggenheim Boosts Roivant Sciences (NASDAQ:ROIV) Price Target to $21.00 - MarketBeat

Sep 22, 2025

Sep 22, 2025

Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings - Reuters

Sep 22, 2025

Sep 22, 2025

What is HC Wainwright's Forecast for ROIV Q1 Earnings? - MarketBeat

Sep 22, 2025

Sep 22, 2025

Leerink Partnrs Has Bullish Estimate for ROIV Q2 Earnings - MarketBeat

Sep 22, 2025

Sep 21, 2025

Roivant Sciences (NASDAQ:ROIV) Hits New 1-Year HighWhat's Next? - MarketBeat

Sep 21, 2025

Sep 21, 2025

Roivant Sciences Hits Day High with Strong 7.76% Intraday Surge - Markets Mojo

Sep 21, 2025

Sep 21, 2025

Roivant Sciences (NASDAQ:ROIV) CEO Matthew Gline Purchases 3,315 Shares - MarketBeat

Sep 21, 2025

Sep 21, 2025

Roivant Sciences (ROIV): Assessing Valuation After Positive Phase 3 Brepocitinib Results in Dermatomyositis Trial - simplywall.st

Sep 21, 2025

Sep 20, 2025

History Review: Will Roivant Sciences Ltd benefit from rate cutsOptions Play & Weekly Watchlist for Hot Stocks - خودرو بانک

Sep 20, 2025

Sep 19, 2025

Ramaswamy Sells $23 Million of Roivant Sciences Stock -- Barron's - 富途牛牛

Sep 19, 2025